
Infinitum Pharma Private Limited
About Infinitum Pharma Private Limited
Data last updated:
Infinitum Pharma Private Limited is a private limited company based in Dehradun, Uttarakhand, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 04 November 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U33309UR2016PTC007385. Its GSTIN is 05AAECI2960E1ZV (Uttarakhand).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shikha Dwivedi and Harish Dwivedi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 31 Mohit Vihar Gms Road Majra, Dehradun, Uttarakhand, India – 248171.
As per the financials filed for FY 2025, the company reported a revenue of ₹54.9 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹5.27 Lakh (net margin 9.6%) and EBITDA of ₹7.26 Lakh (EBITDA margin 13.2%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 5% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Infinitum Pharma Private Limited's registered office is in Dehradun, Uttarakhand. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address31 Mohit Vihar Gms Road Majra, Dehradun, Uttarakhand, India – 248171
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Infinitum Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Infinitum Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Infinitum Pharma Private Limited, buy the company report.
Financials of Infinitum Pharma Private Limited
FY 2025 filings availableInfinitum Pharma Private Limited reported revenue of ₹54.9 Lakh (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 6% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.26 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.27 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.2% | ||||
| Net Profit Margin | 9.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Infinitum Pharma Private Limited, buy the company report.
Board of directors of Infinitum Pharma Private Limited
Infinitum Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shikha Dwivedi Also directs: Infinitum IT Solutions Private Limited | Director | 04 Nov 2016 | 9 Years 11 Months | Current |
| Harish Dwivedi Also directs: Infinitum IT Solutions Private Limited | Director | 18 Mar 2020 | 6 Years 7 Months | Current |
Peer comparison
Infinitum Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ecomate Building Systems Private Limited | ₹54.93 Lakh (FY 2021) | -26.0% | Gurgaon, Haryana, India | |||
| Tacticfield Agro Science Private Limited | ₹54.93 Lakh (FY 2024) | 100.0% | Indore, Madhya Pradesh, India | |||
| Yasashwi International Private Limited | ₹54.92 Lakh (FY 2021) | 560.0% | Kolkata, West Bengal, India | |||
| Sag Fine Punch Private Limited | ₹54.92 Lakh (FY 2022) | -6.0% | Bangalore, Karnataka, India | |||
| Dybs Seeds Private Limited | ₹54.91 Lakh (FY 2024) | 50.0% | Mirzapur, Uttar Pradesh, India | |||
| Infinitum Pharma Private Limitedthis company | ₹54.9 Lakh (FY 2025) | ₹5.27 Lakh | 9.6% | 6.0% | Dehradun, Uttarakhand, India | |
| Synergy Pharmasource Private Limited | ₹54.89 Lakh (FY 2024) | Ahmedabad, Gujarat, India | ||||
| Bookstation Private Limited | ₹54.88 Lakh (FY 2025) | -16.0% | Pune, Maharashtra, India | |||
| Supertex Vinimay Private Limited | ₹54.87 Lakh (FY 2025) | 18.0% | Kolkata, West Bengal, India | |||
| Addwil Care Life Sciences Private Limited | ₹54.86 Lakh (FY 2025) | 2197.0% | Pehowa, Haryana, India | |||
| Desiqua Pvt Ltd | ₹54.86 Lakh (FY 2025) | -29.0% | Rajasthan, India |
To see the full peer comparison of Infinitum Pharma Private Limited, buy the company report.
Auditor
Infinitum Pharma Private Limited is audited by B.MSHARMA&ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B.MSHARMA&ASSOCIATES | FY 2017 | 007944N |
Shareholding
The shareholding of Infinitum Pharma Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Infinitum Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Infinitum Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Infinitum Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Infinitum Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAECI2960E1ZV | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Infinitum Pharma Private Limited, buy the company report.
Recent activity
Infinitum Pharma Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Harish Dwivedi was appointed as Director on 18 Mar 2020.
Frequently asked questions
Infinitum Pharma is an active private limited company based in Dehradun, Uttarakhand, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 04 November 2016 (10+ years old) and is registered under CIN U33309UR2016PTC007385.
Infinitum Pharma has 2 current directors:
- Shikha Dwivedi - Director
- Harish Dwivedi - Director
The latest financial statements of Infinitum Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Infinitum Pharma is 05AAECI2960E1ZV, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Infinitum Pharma is U33309UR2016PTC007385. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Infinitum Pharma was incorporated on 04 November 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Infinitum Pharma by revenue are Ecomate Building Systems Private Limited, Tacticfield Agro Science Private Limited, Yasashwi International Private Limited, Sag Fine Punch Private Limited, Dybs Seeds Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Harish Dwivedi was appointed as Director on 18 Mar 2020. Surendra Kumar Dwivedi ceased to be Director on 01 Feb 2020. Shikha Dwivedi was appointed as Director on 04 Nov 2016.
The registered office of Infinitum Pharma is at 31 Mohit Vihar Gms Road Majra, Dehradun, Uttarakhand, India – 248171.
Infinitum Pharma operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Infinitum Pharma is compliant as of 28 July 2026. The company is actively filing with the Registrar of Companies.

